Top Tweets for #angleplc
Did you miss our exciting new webinar? The full recording of “Novel strategies for circulating tumor cell analysis in glioblastoma” is now available:
https://t.co/wwRg8fU24g
#ANGLEplc #glioblastoma #CancerResearch #CTCs
For Research Use Only. Not for Use in Diagnostic Procedures.
#ANGLE R&D team published promising data using #HER2 assays with circulating tumour cells (CTCs) in breast cancer, demonstrating innovative techniques like (IF) staining and (FISH).
Discover the latest data here: https://t.co/G392GUCZtY
#ANGLEplc #LiquidBiopsy #BreastCancer
At this October Breast Cancer Awareness Month we are proud to gain and spread knowledge of what sufferers are up against and how we all can help.
Join us to raise the awareness today:
https://t.co/12bqI3gyV8
#ANGLEplc #BreastCancerAwareness #CancerResearch #LiquidBiopsy
Biomarkers & Precision Medicine immersive event has started! #ANGLEplc team is onsite to meet with global pharmaceutical leaders and discuss the potential how liquid biopsy could help shape the future of cancer research and clinical trials.
#ANGLEplc #LiquidBiopsy #BIOMUK2025
September is Prostate Cancer Awareness month in the US!
Join us in raising awareness of prostate cancer today!
Help and support cancer research by standing with everyone affected by prostate cancer: https://t.co/CsWpHYIe6x
#ProstateCancer #OncologyResearcg #ANGLEplc
Next week #ANGLEplc will attend the Biomarkers & Precision Medicine Conference in London!
Meet our team to discuss the benefits of including liquid biopsy and CTC analysis in your cancer research or clinical trials.
Secure your 1:1 meeting: https://t.co/Dt6OGYstP6
Our team is live at #WorldCBCDx2025 - connecting with the global professionals in genomic profiling, omics, AI technologies, clinical biomarkers and drug-diagnostics fields. Meet our experts at Booth 23 to discuss your clinical studies.
@BrettSwansiger @MarkRogers
#ANGLEplc
#ACTC2025 is underway, our team is thrilled to be part of it! Visit #ANGLEplc team at Booth 5 to discover the significant potential of circulating tumour cells combining with the novel Parsortix technologies!
@MicheleGiunta @BeatrixThompson
#ANGLEplc #CancerResearch
Are you travelling to #ACTC2025 next week? Don’t miss the poster session and stop by ANGLE’s poster presented by @MicheleGiunta!
Request 1:1 meeting with the ANGLE team and join us at Booth 5 at #ACTC2025: https://t.co/43CPkR2Xif
#ANGLEplc #ACTC2025 #CancerResearch #LiquidBiopsy
The #ANGLEplc team is excited to be attending #ACTC2025 in Thessaloniki next week!
Come and meet us at Booth 5 to discuss how we are revealing the secrets of #CTCs through multiomics.
Book your one-to-one meeting during the event HERE:
https://t.co/43CPkR3v7N
#CancerResearch
We’re thrilled to welcome ANGLE as a Platinum Sponsor of the 7th ACTC Meeting!
Don’t miss their Oral Presentation:
📌 Decoding CTCs through multiomics: Advancing precision monitoring in Oncology
🗓️ Sept 25 | 🕒 15:00–15:30
Meet ANGLE at Booth #5
#ACTC2025
We are proud to support #OvarianCancerAwarenessMonth this September in the USA. #Ovariancancer is the deadliest of all gynecologic cancers.
Join us in raising awareness, supporting research, and standing with everyone affected by ovarian cancer.
https://t.co/4TYDxfFYCs
#ANGLEplc
$ANGLE #ANGLE #ANGLEPLC
@Parsortix #Parsortix
"Our priority now is to capitalise fully on ongoing discussions with large pharma, large medtech, and major healthcare providers," CEO Newland said.
ANGLE said its growing menu of validated cancer assays and ongoing collaborations, including with the UK’s National Health Service, position it well for when market conditions improve.
ANGLE PLC (#AIM:#AGL, #OTCQX:#ANPCY) has highlighted a growing pipeline of work with major pharmaceutical and medical technology groups, saying talks are advancing on a series of high-profile contracts, even as revenues remain under pressure.
The Surrey-based company, which specialises in “liquid biopsies”, blood tests that can detect and analyse cancer cells, said it had completed projects with #AstraZeneca and #Eisai and has further discussions underway.
It also referenced its new tie-up with #Myriad #Genetics to adapt an existing cancer test from tissue samples to blood, which management described as a potentially transformational step.
Andrew Newland, ANGLE’s chief executive, said: “Our agreement ... marks a potentially transformational step towards the large-scale commercialisation of the Parsortix system, providing a pathway to CTCs being adopted into routine clinical use.”
The Parsortix system, ANGLE’s flagship product, isolates circulating tumour cells (CTCs), cancer cells that break away from a tumour and enter the bloodstream.
By analysing these cells alongside fragments of tumour #DNA (#ctDNA), doctors and drugmakers can track how #cancers evolve, which treatments might work best, and when a therapy stops being effective.
Uncover the power of single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients in the study by Acheampong, E. et. al. Read the full article:
https://t.co/wYJvwEzmKw
#CancerResearch #ANGLEplc #LiquidBiopsy #CirculatingTumourCells
#ANGLE’s Parsortix® system uses a patented microfluidic technology in the form of a single use cassette to capture and then harvest circulating tumour cells (CTCs) from whole blood.
Discover more here: https://t.co/Sarf7gEKmh
#CancerResearch #ANGLEplc #LiquidBiopsy #CTC
Did you know that Parsortix® technology from #ANGLEplc can capture a broad phenotypic range of CTCs?
Read the full publication by Dr Asante DB here to find out more: https://t.co/A8NUXxjtMJ
Our DNA damage response (DDR) test is a highly accurate pharmacodynamic assay that provides translation researchers a quantitative measure of an investigational drug’s DNA damage effect.
Learn more: https://t.co/pU07Mp5tuC
#LiquidBiopsy #ANGLEplc
Why to use #ANGLEplc Portrait® Flex immunofluorescence assay?
Learn more about cancer progression & treatment with Portrait Flex assay service.
https://t.co/jYKXXFU9Zr
#LiquidBiopsy #CancerResearch #CTC
#ANGLEplc Portrait® Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal and epithelial-to-mesenchymal transition circulating tumour cells (CTCs).
Learn more about cancer progression: https://t.co/jYKXXFTC9T
#LiquidBiopsy #CancerResearch #CTC
The #ANGLE team attended the #GenomicsEnglandResearchSummit2025 and were blown-away with the Genomics England’s continued mission to secure the UK’s position as the best place to discover, prove, and benefit from genomic innovations.
#ANGLEplc #GenomicsEngland #CancerResearch
Last Seen Hashtags on Sotwe
孕肚
Seen from United States
PeaceWithNature
Seen from United States
momson #nolimit() +filter:native_video
Seen from Vietnam
DhruvaHunt
Instaquince
Seen from United States
지인박제
Seen from Korea
เมืองเลย
Seen from Thailand
pasifantalya
Seen from Turkey
antalyamasaj
Seen from Turkey
colegialas
Seen from Guatemala
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.5M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.2M followers
X
@x
60.8M followers